Alzheimer's Disease
The most common form of dementia. Research reveals a connection between the gut microbiome, neuroinflammation, and amyloid plaque accumulation. Chen Tingtao's experiments on SAMP8 mice demonstrated anti-aging properties of certain strains.
What Is Alzheimer's Disease?
A progressive neurodegenerative disease characterized by the accumulation of amyloid plaques and tau protein in the brain.
About the Disease
Alzheimer's disease accounts for 60-80% of dementia cases. It affects approximately 50 million people worldwide. The risk increases significantly after age 65.
New Understanding: Research shows that microbiome-related neuroinflammation may play a key role in disease development. Chen Tingtao demonstrated anti-aging properties of certain strains in SAMP8 mice.
Symptoms
- Progressive memory loss
- Speech and cognitive impairment
- Disorientation in time and space
- Changes in mood and behavior
- Difficulty with daily activities
The Gut-Brain Connection
- The microbiome influences neuroinflammation and amyloidogenesis
- Bacterial metabolites modulate amyloid-beta deposition
- Intestinal permeability is linked to blood-brain barrier permeability
- Dysbiosis has been found in patients with dementia
Conventional Treatment
Cholinesterase inhibitors, memantine, novel anti-amyloid drugs. Therapy slows but does not halt disease progression.
Treating Alzheimer's disease remains one of the greatest unsolved challenges in medicine. New approaches, including microbiome modulation, are urgently needed.
Why Fecal Microbiota Transplantation (FMT) for Alzheimer's Disease?
Animal studies show that microbiome modulation can influence amyloid accumulation and cognitive function. Neuroprotective properties of certain strains represent a new research frontier.
Dysbiosis
Microbiome changes in Alzheimer's disease
Neuroinflammation
Chronic inflammation, amyloid-beta accumulation
FMT Transplantation
Restoration of a healthy microbiome
Potential Effect
Neuroprotection, reduced inflammation
Scientific Rationale
Patients with Alzheimer's disease have been found to have altered microbiome composition. Chen Tingtao's experiments on SAMP8 mice showed that certain bacterial strains possess anti-aging and neuroprotective properties, reducing amyloid deposits and improving cognitive function.
Potential Mechanisms
- Reduction of systemic and neuroinflammation
- Improved intestinal and blood-brain barrier function
- Neuroprotection through anti-aging strain properties
- Potential reduction of amyloid deposits
Research Results
FMT research for Alzheimer's disease is at an early stage, but animal study results are encouraging. Han's United includes neurodegenerative diseases in its clinical practice.
SAMP8
Mouse model -- positive results
50M+
Dementia patients worldwide
Chen Tingtao
Anti-aging strain research
Phase I
First clinical trials
Key Studies
- Chen Tingtao (SAMP8 experiments): Certain bacterial strains showed anti-aging properties in an accelerated-aging mouse model, reducing neuroinflammation
- Vogt et al., Scientific Reports 2017: Characteristic microbiome changes described in Alzheimer's disease
- Kim et al., Brain Behavior Immunity 2020: FMT from healthy mice reduced amyloid plaques in model animals
- Clinical trials 2024-2026: First Phase I studies of FMT for dementia initiated at several centers
Free consultation · We respond within 24 hours
Treatment Perspectives
A look at the future of Alzheimer's disease therapy
"Alzheimer's disease is one of the most complex challenges in modern medicine. The discovery of the connection between the microbiome and neurodegeneration opens a fundamentally new therapeutic approach. Experiments on SAMP8 mice showed that certain strains can slow brain aging. We are on the verge of a potential breakthrough."
Scientific Community
International Neurodegeneration Research
Related Conditions
FMT is also being studied for other neurodegenerative diseases
Autism (ASD)
Developmental disorder with communication and behavioral features
Parkinson's
Neurodegenerative disease with motor impairment
ALS
Progressive motor neuron degeneration
Depression
Mood disorder with persistent emotional decline
Related Articles
Have Questions About New Treatment Methods?
If you or a loved one has Alzheimer's disease, contact us via Telegram or WhatsApp. We will share information about current research and available options.
Free consultation · We respond within 24 hours
China, Jiangxi Province, Shangrao City, Guangxin District, West Binjiang Road